Xenetic Biosciences Inc
For the period ended Dec 31, 2023. Filed Mar 21, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 21, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Power of Attorney
POWER OF ATTORNEY AND SIGNATURES
We, the undersigned officers and directors of Xenetic Biosciences, Inc., hereby severally constitute and appoint Jeffrey F. Eisenberg, our true and lawful attorney, with full power to him, to sign for us in our names in the capacities indicated below, all amendments to this report, and generally to do all things in our names and on our behalf in such capacities to enable Xenetic Biosciences, Inc. to comply with the provisions of the Securities Exchange Act of 1934, as amended, and all requirements of the Securities and Exchange Commission.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated below on the 21st day of March, 2024.
| Signature | Title(s) |
|---|---|
| /s/ JEFFREY F. EISENBERG | Chief Executive Officer and Director (Principal Executive Officer) |
| Jeffrey F. Eisenberg | |
| /s/ JAMES PARSLOW | Chief Financial Officer |
| James Parslow | (Principal Financial Officer and Principal Accounting Officer) |
| /s/ GRIGORY BORISENKO | Director |
| Grigory Borisenko | |
| /s/ JAMES CALLAWAY | Director |
| James Callaway | |
| /s/ FIRDAUS JAL DASTOOR | Director |
| Firdaus Jal Dastoor | |
| /s/ Dmitry Genkin | Director |
| Dmitry Genkin | |
| /s/ ROGER KORNBERG | Director |
| Roger Kornberg | |
| /s/ ADAM LOGAL | Director |
| Adam Logal | |
| Director | |
| Moshe Mizrahy | |
| /s/ ALEXEY VINOGRADOV | Director |
| Alexey Vinogradov | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.